What a tragedy it would be if this year’s annual report on the status of cancer in this country was the last one to show progress against this devastating disease.
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central Cancer Registries, and the National Cancer Institute late last month.
Death rates from the disease have fallen steadily since the beginning of this century.
Between 2018 and 2022, they declined 1.5% per year.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Is Era of Biomedical Innovation Wins Against Cancer Over?
Sally C. Pipes
What a tragedy it would be if this year’s annual report on the status of cancer in this country was the last one to show progress against this devastating disease.
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central Cancer Registries, and the National Cancer Institute late last month.
Death rates from the disease have fallen steadily since the beginning of this century.
Between 2018 and 2022, they declined 1.5% per year.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.